Mixed Mullerian Tumor Primitive of Peritoneum: Report of a Case

Stefania Erra, Simone Lo Mastro, Ennio Nano


Carcinosarcoma is a rare and aggressive cancer that usually affects women in post menopausae; it represents 3% of all uterine neoplasms. Carcinosarcoma is a biphasic tumor characterized by a double component: a carcinomatous and a sarcomatous one, in variable amount of percentage from case to case. In the present article, a very rare case of primitive peritoneal carcinosarcoma is described in an 86-year-old woman, with senile atrophy of the uterus.


Carcinosarcoma; mullerian mixed tumor; peritoneum.

Full Text:



Arend Rebecca, Doneza Janine A, Wright Jason D (2011). Uterine Carcinosarcoma. Current Opinion in Oncology. 23(5):531-536.

Barwick KW, LiVolsi VA (1979). Malignant mixed mullerian tumors of the uterus. Amer. J. Surg. Pathol. 3:125-135.

De Brito PA, Silverberg SG, Orenstein JM (1993). Carcinosar- coma (malignant mixed mullerian mesodermal tumor) of the female genital tract. Immunoistochemical and ultrastructural analysis of 28 cases. Human pathology. 24:132-142.

Donner Ludvik R (2003). Uterine Carcinosarcoma with Com- plete Sarcomatous Overgrowth Mimicking Pure Embryonal Rhabdomyosarcoma. International Journal of Gynecological Pathology. 22(1):89-91.

Ferguson SE, Tornos C, Hummer A, Barakat RR, Soslow RA (2007). Prognostic features of surgical stage I uterine carci- nosarcoma. Am J Surg Pathol. 31(11):1653-1661.

Gersell DJ, Duncan DA, Fulling KH (1989). Malignant mixed müllerian tumor of the uterus with neuroectodermal differ- entiation. Int. J. Gynecol. Pathol. 8:169-178

Makoto Emoto, Hiroshi Iwasaki, Masako Ishiguro, Masa- hiro Kikuchi, et al (1999). Angiogenesis in carcinosarcomas of the uterus: Differences in the microvessel density and expression of vascular endothelial growth factor between the epithelial and mesenchymal elements. Human Pathology. 30(10):1232-1241.

Michael J Costa, Judy Walls HT (1996). Epidermal growth factor receptor and c-erbB-2 oncoprotein expression in female genital tract carcinosarcomas (Malignant mixed müllerian tumors): Clinicopathologic study of 82 cases. Cancer: Publica- tion cover image. 77(3):533-542.

P Bitterman, B Chun, Robert J Kurman (1990). The significance of epithelial differentiation in mixed mesodermal tumors of the uterus. A clinicopathologic and immunohistochemical study. American Journal of Surgical Pathology. 14(4):317-328.

Wolfson AH, Brady MF, Rocereto T, Mannel RS, Lee YC, et al (2007). A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin- ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus. GynecolOncol. 107(2):177-185.

Wada H, Enomoto T, Fujita M, Yoshino K, et al (1997). Molecu- lar evidence that most but not all carcinosarcomas of the uterus are combination tumors. Cancer Res. 57(23):5379-5385.

DOI: http://dx.doi.org/10.21477/ijapsr.4.1.1


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Creative Commons License
International Journal of Applied Pharmaceutical Sciences and Research by Sierra Journals is licensed under a creativecommons.org/licenses/by/4.0/. https://creativecommons.org/licenses/by/4.0/
Based on a work at http://www.sierrajournals.com/direct/index.php/IJAPSR/issue/archive